Carbon nanotubes: An alternative for platinum-based drugs delivery systems

被引：0

作者：

Salas-Trevino, Daniel ^{[1
]}

Saucedo-Cardenas, Odila ^{[1
,2
]}

de Jesus Loera-Arias, Maria ^{[1
]}

Gerardo De Casas-Ortiz, Edgar ^{[3
]}

Rodriguez-Rocha, Humberto ^{[1
]}

Garcia-Garcia, Aracely ^{[1
]}

Montes-de-Oca-Luna, Roberto ^{[1
]}

Soto-Dominguez, Adolfo ^{[1
]}

机构：

[1] Autonomous Univ Nuevo Leon, Dept Histol, Fac Med, Monterrey 66460, Nuevo Leon, Mexico

[2] IMSS, Northeast Biomed Res Ctr CIBIN, Monterrey, Nuevo Leon, Mexico

[3] Appl Chem Res Ctr CIQA, Dept Adv Mat, Saltillo, Coahuila, Mexico

来源：

JOURNAL OF BUON | 2018年 / 23卷 / 03期

关键词：

cancer; carbon nanotubes; drug delivery; chemotherapy; platinum-based drugs; CANCER-CELLS; IN-VIVO; RELEASE; CISPLATIN; TOXICITY; DIAMETER; EFFICACY; ENCAPSULATION; NANOMEDICINE; CYTOTOXICITY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Currently, nanomedicine is approaching the research of nanomaterials that could work as drug delivery systems, to increase the efficiency, specificity and safety of drugs reducing toxicity and side effects. In this regard, carbon nanotubes have acquired great interest due to their physicochemical properties. The use of platinum-based drugs is facing some troubles in the clinic due to their side effects such as nephrotoxicity, neutropenia, neurotoxicity, among others. In addition, cases of tumors resistant to these drugs have been recently observed. The goal of this review was to analyze the reports about the use of formulations of platinum-based drugs in carbon nanotubes, to know and establish the most functional and potential conditions for its use in cancer treatment, identifying perspectives and develop areas for the improvement of these nanomaterials in the application of cancer therapy.

引用

页码：541 / 549

页数：9

共 50 条

[21] Chemical Imaging of Platinum-Based Drugs and their Metabolites
Xin Liu
Amanda B. Hummon
Scientific Reports, 6
[22] Chemical Imaging of Platinum-Based Drugs and their Metabolites
Liu, Xin
Hummon, Amanda B.
SCIENTIFIC REPORTS, 2016, 6
[23] Platinum-based drugs: past, present and future
Dilruba, Shahana
Kalayda, Ganna V.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (06) : 1103 - 1124
[24] Platinum-based drugs: past, present and future
Shahana Dilruba
Ganna V. Kalayda
Cancer Chemotherapy and Pharmacology, 2016, 77 : 1103 - 1124
[25] Role of transporters in the distribution of platinum-based drugs
Harrach, Saliha
Ciarimboli, Giuliano
FRONTIERS IN PHARMACOLOGY, 2015, 6
[26] Novel ionic liquid supported synthesis of platinum-based electrocatalysts on multiwalled carbon nanotubes
Zhao, ZW
Guo, ZP
Ding, J
Wexler, D
Ma, ZF
Zhang, DY
Liu, HK
ELECTROCHEMISTRY COMMUNICATIONS, 2006, 8 (02) : 245 - 250
[27] Drug Delivery Strategies for Platinum-Based Chemotherapy
Browning, Richard J.
Reardon, Philip James Thomas
Parhizkar, Maryam
Pedley, R. Barbara
Edirisinghe, Mohan
Knowles, Jonathan C.
Stride, Eleanor
ACS NANO, 2017, 11 (09) : 8560 - 8578
[28] Targeted delivery of platinum-based anticancer complexes
Butler, Jennifer S.
Sadler, Peter J.
CURRENT OPINION IN CHEMICAL BIOLOGY, 2013, 17 (02) : 175 - 188
[29] Fighting the resistance: rejuvenating anticancer platinum-based drugs
O'Hare, Alice
THERAPEUTIC DELIVERY, 2012, 3 (07) : 810 - 810
[30] Performance improvement of platinum-based electrocatalyst layer for PEFC by mixing single walled carbon nanotubes
Kishida K.
Harigai T.
Takikawa H.
Hashimoto T.
Harigai, Toru (harigai.toru.un@tut.jp), 1600, Institute of Electrical Engineers of Japan (141): : 316 - 321

← 1 2 3 4 5 →